ResMed Inc. (FRA:RME)

Germany flag Germany · Delayed Price · Currency is EUR
217.80
-0.20 (-0.09%)
At close: Jun 6, 2025, 10:00 PM CET
13.00%
Market Cap 32.41B
Revenue (ttm) 4.65B
Net Income (ttm) 1.22B
Shares Out n/a
EPS (ttm) 8.24
PE Ratio 26.68
Forward PE 24.67
Dividend 1.95 (0.91%)
Ex-Dividend Date May 8, 2025
Volume n/a
Average Volume 17
Open 217.80
Previous Close 218.00
Day's Range 217.80 - 217.80
52-Week Range 162.65 - 248.90
Beta n/a
RSI 57.87
Earnings Date Aug 1, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1989
Employees 9,980
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol RME
Full Company Profile

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Financial numbers in USD Financial Statements

News

There is no news available yet.